Immunovant, Inc. (IMVT) Earnings
NASDAQ·Healthcare·Biotechnology
$34.51
-7.47%
Mkt Cap $7.67B
EPS — Estimate vs Actual
Mkt Cap
$7.67B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.78
NASDAQ·Healthcare·Biotechnology
$34.51
-7.47%
Mkt Cap $7.67B
Mkt Cap
$7.67B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.78